Webinar: Environmental Sustainability and the Supply of Medicines for Clinical Trials
Did you know that the healthcare sector is responsible for nearly 5 percent of global emissions, with the pharmaceutical industry being a significant contributor?
Â
The pharma industry’s emission intensity is almost 55 percent higher than that of the automotive sector and 71 percent of those emissions come from the supply chain.
Despite a compound annual growth rate (CAGR) of around 15 percent, big pharma’s emissions are on a downward trend, showcasing their leadership in sustainability practices. The rest of the industry is following suit by measuring the baseline and setting targets that align with global ambitions.
In this webinar, Mark Ware explores environmental sustainability as it relates to the supply of medicines for use in clinical trials and identify the key contributing factors. He will walk through the structure and categorization of emissions, how they can be measured, how targets are set and most importantly how they can be achieved.
Â
Replay this educational session where we discuss how major pharma companies are working towards environmental sustainability and reducing their environmental impact.
Speaker: Mark Ware
Chief Commercial Officer at Inceptua.
Mark has over 20 years of experience in clinical trial supplies, clinical services, pre-approval access and business development. He also leads Inceptua’s Global Clinical Trial Supply Team. He is keenly interested in sustainability and ensuring services are tailored to what pharma and biotech companies truly need to keep patients supported throughout the life of a clinical trial.